| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $59.4M | -7.9% |
| SG&A Expense | $27.1M | -4.5% |
| Operating Income | -$86.5M | +6.9% |
| Income Tax | $0 | — |
| Net Income | -$82.4M | +9.6% |
| EPS (Basic) | -$1.88 | +25.4% |
| EPS (Diluted) | -$1.88 | +25.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.2M | +63.8% |
| Current Assets | $134.0M | +5.0% |
| Total Assets | $158.6M | +1.5% |
| Current Liabilities | $19.6M | +28.7% |
| Total Liabilities | $41.8M | +3.1% |
| Stockholders' Equity | $116.7M | +0.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.7M | +21.6% |
| Capital Expenditures | $33K | -82.8% |
| Investing Cash Flow | $16.3M | -69.4% |
| Financing Cash Flow | $71.9M | — |
| Free Cash Flow | -$66.8M | +21.7% |